Technical Analysis for TTOO - T2 Biosystems, Inc.

Grade Last Price % Change Price Change
grade B 2.88 -4.32% -0.13
TTOO closed down 4.32 percent on Friday, September 13, 2019, on 1.97 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical TTOO trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
200 DMA Support Bullish -4.32%
New Uptrend Bullish -4.32%
Pocket Pivot Bullish Swing Setup -4.32%
Volume Surge Other -4.32%

Older signals for TTOO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products based on its proprietary platform. Its T2 Magnetic Resonance platform enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company offers T2Dx, a bench-top instrument, which has completed a pivotal clinical trial for performing diagnostic tests in sepsis and other applications; and T2Stat, an integrated instrument for hemostasis applications. It is also developing T2Candida panel that has completed a pivotal clinical trial for identifying pathogens associated with sepsis; T2HemoStat panel, which includes a set of hemostasis measurements, including platelet function, clotting time, and clot degradation; and T2Bacteria, a multiplex diagnostic panel that detects the bacterial pathogens associated with sepsis. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Medicine Medical Specialties Cell Biology Diagnostic Tests Diagnostic Products Blood Intensive Care Medicine Coagulation System Coagulation In Vitro Diagnostics Platelet Sepsis Hemostasis
Is TTOO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.7
52 Week Low 0.52
Average Volume 2,283,880
200-Day Moving Average 2.577
50-Day Moving Average 1.3481
20-Day Moving Average 1.507
10-Day Moving Average 1.841
Average True Range 0.2822
ADX 28.26
+DI 49.4163
-DI 9.9349
Chandelier Exit (Long, 3 ATRs ) 2.3634
Chandelier Exit (Short, 3 ATRs ) 1.5866
Upper Bollinger Band 2.6991
Lower Bollinger Band 0.3149
Percent B (%b) 1.08
BandWidth 158.208361
MACD Line 0.3458
MACD Signal Line 0.1573
MACD Histogram 0.1885
Fundamentals Value
Market Cap 88.6 Million
Num Shares 30.8 Million
EPS -1.97
Price-to-Earnings (P/E) Ratio -1.46
Price-to-Sales 31.86
Price-to-Book 10.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.48
Resistance 3 (R3) 3.49 3.30 3.38
Resistance 2 (R2) 3.30 3.15 3.30 3.35
Resistance 1 (R1) 3.09 3.05 3.00 3.08 3.31
Pivot Point 2.90 2.90 2.85 2.90 2.90
Support 1 (S1) 2.69 2.75 2.60 2.68 2.45
Support 2 (S2) 2.50 2.65 2.50 2.41
Support 3 (S3) 2.29 2.50 2.38
Support 4 (S4) 2.28